New Guideline Calls For Annual Incontinence Screening for Women

New Guideline Calls For Annual Incontinence Screening for Women

A new guideline recommends that women of all ages — including adolescents — receive an annual screening for urinary incontinence.

The Women’s Preventive Service Initiative, composed of women’s health organizations and patient advocates, said the screening should determine if a woman suffers from incontinence, and if so, if it impacts their activities and quality of life. The group says 51% off women suffer from incontinence, and 55% of women with the condition don’t report symptoms to their doctors.

The recommendation says that there is no direct evidence on the benefits or harms of screenings as there have been no trials conducted on whether screenings improve symptoms, quality of life and function. An evidence review found insufficient evidence on the effectiveness and harms of the screening.

An editorial published in the Annals of Internal Medicine advised caution on the screening recommendation. “Rather than recommending annual screening for women across the lifespan, we should be advocating a randomized trial to directly assess the benefit and harm of [screening] in women. This trial should be designed to assess the benefit-harm balance for screen at different life stages (from adolescence to old age) and to identify high-risk groups…for whom the benefits of screening might outweigh the risks.”


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement